Ward, and H
Notably: BPC-157, KPV, MOTs-C, Emideltide (DSIP), Epitalon, Semax (heptapeptide) and TB-500 are among those expected to be reviewed in July 2026 Other substances, including Cathelicidin LL-37, Dihexa Acetate, PEG-MGF, GHK-Cu and Melanotan II, are under consideration for review by early 2027 Non-injectable GHK-Cu is following a slightly different path, with separate evaluation anticipated before February 2027
Although erythropoiesis is enhanced, anemia likely continues due to elevated erythropoietin levels, which paradoxically heighten the vulnerability of RBCs to eryptosis
There are benefits and downsides to switching from Wegovy injections to Wegovy tablets
Whole foods are safe and environmentally friendly sources of nutrients compared to dietary supplements, which are beneficial in cases of deficiency and should be used as directed by a doctor
The results of Look AHEAD do not row against the implementation of lifestyle changes in patients with type 2 diabetes